(Total Views: 722)
Posted On: 02/23/2021 7:04:01 AM
Post# of 153887
I am a long-term investor for many years...
...BUT i hope NP knows what he’s doing
I think it is a very bad idea not telling NOW the CD-12 results to the shareholders because when later it turns out that CD-12 was good but not good enough Cytodyn is going to pay a big bill...
I think that NP is clever enough to analyse the results on his own or with his Cyto-team and i am sure that NP knows what the results should be to get approval....so telling the world that he is in discussion now is , i think, a very bad move...why NP did not said:..”following a very strong mortality rate in our CD12 results, we are now kn discussion with......””
Also, the FDA does not discuss!!
The FDA will look at the results and will approve or will not approve!!
Does somebody really believe that the FDA is going to have a discussion with NP to look and say:..”aah Nader, what can we do for you??...”
We will see in 2 weeks....
...BUT i hope NP knows what he’s doing
I think it is a very bad idea not telling NOW the CD-12 results to the shareholders because when later it turns out that CD-12 was good but not good enough Cytodyn is going to pay a big bill...
I think that NP is clever enough to analyse the results on his own or with his Cyto-team and i am sure that NP knows what the results should be to get approval....so telling the world that he is in discussion now is , i think, a very bad move...why NP did not said:..”following a very strong mortality rate in our CD12 results, we are now kn discussion with......””
Also, the FDA does not discuss!!
The FDA will look at the results and will approve or will not approve!!
Does somebody really believe that the FDA is going to have a discussion with NP to look and say:..”aah Nader, what can we do for you??...”
We will see in 2 weeks....
(4)
(6)
